Literature DB >> 32118761

Diabetes mellitus as a risk factor for retinal vein occlusion: A meta-analysis.

Yun Wang1, Shanjun Wu1, Feng Wen1, Qixin Cao2.   

Abstract

Retinal vein occlusion (RVO) is the second most common etiology for vision loss. There is contrasting evidence on the association between diabetes mellitus (DM) and the risk of RVO. We performed a meta-analysis of published articles before October 31, 2019, to estimate a pooled odds ratio for the association between DM and RVO, including central and branch RVO by a fixed or random effects model. We identified 37 publications from 38 studies (1 publication was from 2 studies), published between 1985 and 2019. In total, 148,654 cases and 23,768,820 controls were included in this meta-analysis. The results of pooled analysis for all 37 publications (or 38 studies) showed a significant association between DM and the risk of RVO (OR = 1.68, 95% CI: 1.43-1.99). Subgroup analysis indicated that DM was significantly associated with CRVO (OR = 1.98, 95% CI: 1.29-3.03, I = 67.9%), but not significantly associated with BRVO (OR = 1.22, 95% CI: 0.95-1.56, I = 64.1%). In conclusion, the result of present meta-analysis suggested that DM is a risk factor for RVO. More well-designed studies on the relationship between RVO and DM should be undertaken in the future.

Entities:  

Year:  2020        PMID: 32118761     DOI: 10.1097/MD.0000000000019319

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  2 in total

1.  Comment on: Central retinal vein occlusion post-COVID-19 vaccination.

Authors:  Pradeep K Panigrahi
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

2.  Wide-Field Fluorescein Angiography in the Diagnosis and Management of Retinal Vein Occlusion: A Retrospective Single-Center Study.

Authors:  Monika J Turczyńska; Przemysław Krajewski; Joanna E Brydak-Godowska
Journal:  Med Sci Monit       Date:  2021-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.